APLSBiotechnology / Biotechnology
Apellis Pharmaceuticals Inc
30-Day Price
Key Metrics
Latest Close
$17.21
Market Cap
$2.3B
Shares Outstanding
127,830,000
P/E Ratio
102.15
P/B Ratio
8.59
ROE
605.00%
ROA
208.00%
Gross Margin
8981.00%
Operating Margin
552.00%
Net Margin
223.00%
Debt / Equity
1.23
Current Ratio
3.14
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free